about
Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependenceUnobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trialBuprenorphine treatment in an urban community health center: what to expectHome- versus office-based buprenorphine inductions for opioid-dependent patients.Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experienceAntidepressant treatment does not improve buprenorphine retention among opioid-dependent personsA comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions.A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphineBuprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centersBuprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.Treating homeless opioid dependent patients with buprenorphine in an office-based setting.Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.Treating opioid addiction with buprenorphine-naloxone in community-based primary care settingsComparison of buprenorphine treatment for opioid dependence in 3 settingsAgonist-antagonist combinations in opioid dependence: a translational approachCost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.Human immunodeficiency virus testing practices among buprenorphine-prescribing physiciansLong-term retention in Office Based Opioid Treatment with buprenorphine.Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatmentTreating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems.Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence.Predictors of outcome after short-term stabilization with buprenorphineBuprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.Office-based management of opioid dependence with buprenorphine: clinical practices and barriersIntegrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes.A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomesCounselor training and attitudes toward pharmacotherapies for opioid use disorder.Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.Narrative review: buprenorphine for opioid-dependent patients in office practice.Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.Retention in methadone and buprenorphine treatment among African Americans.Home buprenorphine/naloxone induction in primary careCost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.Community-based treatment for opioid dependent offenders: a pilot studySubstance-related problems and treatment among men who have sex with men in comparison to other men in Chicago.
P2860
Q28265279-79E9A08C-0FD1-464C-94E7-079F77417DB6Q30432435-74EF0C50-62D4-4B7F-A136-AEFC2769F2E5Q33735289-AF234506-64C2-49DA-8604-B40F4D16CBE9Q33769847-34DA9EB4-5580-4D89-BD1C-07690327C214Q33776944-28FD72F2-597A-409C-B69D-9831D4B7C45AQ33845768-4C4595F6-E133-410D-822C-C11D664D571EQ34023435-6F802A44-CE4D-45E0-92C7-E64F9963D36FQ34850334-E8941682-DCCC-4FA0-843D-3014607B1F06Q34980314-AE6C4C42-8FE4-43D6-839B-1DD8E27DF6F9Q35112836-7E199AA0-602B-4E41-AED5-479E67419850Q35228546-AEB5D952-D788-4BBC-A74A-10BE9342948CQ35683055-E9AA66CC-C7D1-4616-85B2-F4B409A03129Q35687716-52E42C83-921E-4220-A535-A4DABADA2A28Q35691511-B57DD9C8-DAC4-49B2-9947-96AF70ECD6CBQ35721931-281B5DFD-426B-4FB2-80F0-58EE5375E3A8Q35748679-EC165A28-72EA-4288-80A9-D54269643122Q35848930-69286B37-8907-40A8-8FF3-FDAD02F5DC20Q35980664-8A490DC6-7498-4263-8128-A8079F07206EQ36249927-C06A6E10-56A9-413E-8763-A5854E73F0DCQ36263379-35C6008C-4A1F-4CB1-AF33-3A192150F580Q36362007-1963B2BB-19D3-4CEF-A745-B9385655A92DQ36364490-30FB6D1F-9300-42C5-A098-D0DEF76F5520Q36367544-E24FD340-A2ED-464F-AEC1-7D331C935632Q36431907-21812FA1-804A-4E57-9FCB-710946C385EFQ36476423-F193A6B6-984F-41A0-B7D3-9BB51E2E6981Q36508384-E585D616-1AD6-4CEC-988D-F803C958F6E0Q36532956-E9684ABD-CE44-4E22-BB53-F24C6C7012B6Q36738043-EF5278F6-A71C-49A6-B29F-DF200C5AFF43Q36841125-D7125ACB-F088-4BE7-9E54-2883ECAE3C03Q36906548-E26ECDF7-D9CA-4639-9F24-F6B9A62448B6Q36926561-BF42BC1E-719E-43CD-928D-B8492F9860CDQ36934945-11DF1F9F-1FE6-4FCF-9097-8BF7EB2AE545Q36952763-E05300DD-866B-4F4B-8AA8-018B16BE9BDCQ36959052-CC595C06-3247-4FE9-ABDA-024D88E99954Q36960916-CFC72FC2-07BB-4BF5-982A-5A6800406297Q37022122-CA85B636-0A35-4680-867B-566528CA6C5EQ37067770-CC24F320-F093-4441-BDEC-82B2ECE8196DQ37105100-50F48CFF-7287-4BE9-869F-28F1738625F1Q37107672-B8B0E32D-AF97-438B-9193-C91156900A1EQ37119303-C818E51A-0C0B-4C2F-96D7-EC06AFAF77FF
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Buprenorphine retention in primary care.
@ast
Buprenorphine retention in primary care.
@en
Buprenorphine retention in primary care.
@nl
type
label
Buprenorphine retention in primary care.
@ast
Buprenorphine retention in primary care.
@en
Buprenorphine retention in primary care.
@nl
prefLabel
Buprenorphine retention in primary care.
@ast
Buprenorphine retention in primary care.
@en
Buprenorphine retention in primary care.
@nl
P2093
P2860
P1476
Buprenorphine retention in primary care.
@en
P2093
Michael D Stein
Patricia Cioe
Peter D Friedmann
P2860
P304
P356
10.1111/J.1525-1497.2005.0228.X
P577
2005-11-01T00:00:00Z
P5875
P6179
1042348001